FewerJobs.
Employers

Employer profile

Kernal Biologics

4 open roles indexed with location, benefit, and apply-link signals where available.

Employer site ATS: greenhouse Top-startup signal

Open roles

Showing the most recent indexed roles for this employer.

Search all matching jobs
  • Senior Scientist, LNP Formulation

    Boston, MA

    unspecified Salary not disclosed

    Senior Scientist, LNP Formulation Boston, MA Kernal Bio is a venture-backed therapeutics company engineering cells inside the body using AI-designed, selective mRNA and targeted LNP technology. By developing in vivo CAR-T therapies, Kernal Bio is advancing precision treatments for autoimmune diseases and blood cancers. The company was founded by experts from MIT, Harvard, Merck, and BMS, and its leadership team brings a track record of three FDA-approved therapies and over 120 patents. Based in Boston, the company is backed by Hummingbird Ventures, Amgen, Lilly, HBM, ARPA-H, and NVIDIA. Kernal Bio is transforming the future of cell therapy design and delivery. Job Summary: Kernal Bio seeks an exceptional, highly motivated Senior Scientist to contribute to developing its targeting lipid nanoparticle platform. The successful candidate will work as part of the team responsible for developing and characterizing the manufacturing process of lipid nanoparticle systems, supporting the tech transfer to the CMC team and external partners, and analyzing/presenting results. The successful candidate must be able to work in a fast paced and highly dynamic Biotech environment. Ideal candidate will be a great team player with excellent communication skills. Responsibilities: Develop and characterize novel LNP formulations and components using Dynamic Light Scattering, Ribogreen, HPLC, etc. Support the design and execution of flow cytometry-related experiments pertaining to LNP screening and optimization. Screen final formulation buffers and excipients to improve the long-term stability of LNPs Execute in vivo experiments with LNP compositions Develop new assays or detailed investigations of specific LNP attributes as required. Development, optimization,

  • Co-op, Synthetic Biology (mRNA Therapeutics)

    Boston, MA (Seaport)

    onsite $20-$25/hr

    Co-op, Synthetic Biology (mRNA Therapeutics) Boston, MA (Seaport) Full-time Co-op (≥6 months) · In person · Boston, MA (Seaport) About Kernal Biologics, Inc. Kernal Bio is a venture-backed therapeutics company engineering cells inside the body using AI-designed, selective mRNA and targeted LNP technology. By developing in vivo CAR-T therapies, Kernal Bio is advancing precision treatments for autoimmune diseases and blood cancers. The company was founded by experts from MIT, Harvard, Merck, and BMS, and its leadership team brings a track record of three FDA-approved therapies and over 120 patents. With support from leading investors, including Hummingbird Ventures, Amgen Ventures, Y Combinator, and HBM, Kernal Bio is transforming the future of cell therapy design and delivery. Job Summary We are seeking a highly motivated researcher to fill a Co-op position on our Synthetic Biology team, supporting the design, production, and in vitro testing of mRNA therapeutics. This is a hands-on, bench-based role: you will work with mammalian cell lines every day, transfect and test mRNAs, and support DNA template and mRNA production, while learning cutting-edge mRNA and synthetic biology technologies as an integral member of the team. You will perform experimental research, document it, and present your results. Key Responsibilities Maintain human and murine cell lines: sterile technique, passaging, cell counting and viability, cryopreservation Transfect IVT mRNAs and LNP-formulated mRNAs into mammalian cells and quantify expression by flow cytometry Support DNA template design and construction (primer design, PCR, DNA assembly, plasmid prep and QC) Support internal mRNA production and quality analysis

  • Director, LNP Formulation

    Cambridge, MA

    unspecified Salary not disclosed

    Director, LNP Formulation Cambridge, MA About Kernal Biologics, Inc. Kernal Bio is a venture-backed therapeutics company engineering cells inside the body using AI-designed, selective mRNA and targeted LNP technology. By developing in vivo CAR-T therapies, Kernal Bio is advancing precision treatments for autoimmune diseases and blood cancers. The company was founded by experts from MIT, Harvard, Merck, and BMS, and its leadership team brings a track record of three FDA-approved therapies and over 120 patents. Based in Boston, the company is backed by Hummingbird Ventures, Amgen, Lilly, HBM, ARPA-H, and NVIDIA. Kernal Bio is transforming the future of cell therapy design and delivery. Job Summary: Kernal is seeking an individual with deep expertise in RNA delivery space to lead our mRNA delivery efforts. This person will report to the SVP of R&D and will be responsible for overseeing the development novel LNP (lipid nanoparticle) systems for in vivo mRNA delivery to support our immuno-oncology and immunology efforts. The successful candidate must be able to work in a fast paced and highly dynamic biotech environment. Ideal candidate will be a leader and a great team player with excellent communication skills and effective, inspiring management style. Responsibilities: Oversee the development of novel LNP compositions Improve existing LNP formulations Manage company's LNP team Advance targeted LNP delivery with novel approaches for in situ mRNA delivery Oversee physicochemical characterization of LNP formulations Work closely with internal teams and external collaborators and ensure delivery on key milestones Guide company's RNA delivery strategy, with a particular

  • Associate Director/Director of Preclinical Development

    Boston, MA

    unspecified Salary not disclosed

    Associate Director/Director of Preclinical Development Boston, MA About Kernal Biologics, Inc. Kernal Bio is a venture-backed therapeutics company engineering cells inside the body using AI-designed, selective mRNA and targeted LNP technology. By developing in vivo CAR-T therapies, Kernal Bio is advancing precision treatments for autoimmune diseases and blood cancers. The company was founded by experts from MIT, Harvard, Merck, and BMS, and its leadership team brings a track record of three FDA-approved therapies and over 120 patents. Based in Boston, the company is backed by Hummingbird Ventures, Amgen, Lilly, HBM, ARPA-H, and NVIDIA. Kernal Bio is transforming the future of cell therapy design and delivery. Job Summary: Kernal Bio is seeking an experienced leader with deep expertise in immunology to lead our mRNA therapeutics efforts. This person will report to the Senior Vice President of R&D and will be responsible for leading preclinical development activities in immunology. In addition, this person will work closely with computational biology and mRNA delivery leadership to execute on company goals. The successful candidate must be able to work in a fast-paced and highly dynamic start-up environment. Ideal candidate will be an inspirational leader and a great team player with a proven track record in drug development, excellent communication skills, and effective management style. Responsibilities: Guide company's preclinical immunology efforts for mRNA 2.0 therapeutics. Independently design, execute, oversee, and analyze preclinical pharmacology, toxicology, DMPK studies for in vivo CAR-T programs. Work collaboratively with internal and external cross-functional teams, collaborators, funding agencies, and SAB members to